- Home
- IMMX vs GORV Comparison
IMMX vs GORV Comparison
Compare IMMX & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GORV
- Stock Information
- Founded
- IMMX 2014
- GORV 1976
- Country
- IMMX United States
- GORV United States
- Employees
- IMMX N/A
- GORV N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- IMMX Health Care
- GORV Consumer Discretionary
- Exchange
- IMMX Nasdaq
- GORV Nasdaq
- Market Cap
- IMMX 55.3M
- GORV 83.3M
- IPO Year
- IMMX 2021
- GORV 2015
- Fundamental
- Price
- IMMX $1.76
- GORV $0.76
- Analyst Decision
- IMMX Strong Buy
- GORV Hold
- Analyst Count
- IMMX 1
- GORV 2
- Target Price
- IMMX $7.00
- GORV $2.00
- AVG Volume (30 Days)
- IMMX 83.5K
- GORV 60.1K
- Earning Date
- IMMX 03-28-2025
- GORV 03-07-2025
- Dividend Yield
- IMMX N/A
- GORV N/A
- EPS Growth
- IMMX N/A
- GORV N/A
- EPS
- IMMX N/A
- GORV N/A
- Revenue
- IMMX N/A
- GORV $920,774,000.00
- Revenue This Year
- IMMX N/A
- GORV N/A
- Revenue Next Year
- IMMX $600.00
- GORV $6.13
- P/E Ratio
- IMMX N/A
- GORV N/A
- Revenue Growth
- IMMX N/A
- GORV N/A
- 52 Week Low
- IMMX $1.26
- GORV $0.66
- 52 Week High
- IMMX $3.80
- GORV $4.74
- Technical
- Relative Strength Index (RSI)
- IMMX 31.71
- GORV 43.29
- Support Level
- IMMX $1.85
- GORV $0.73
- Resistance Level
- IMMX $2.14
- GORV $0.82
- Average True Range (ATR)
- IMMX 0.12
- GORV 0.09
- MACD
- IMMX -0.02
- GORV 0.00
- Stochastic Oscillator
- IMMX 8.43
- GORV 48.22
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.